A disconcerting 59% of investor respondents consider under one quarter of the life science management teams they see each year to be effective managers, according to the Investor Perception Survey 2018, published in February 2018. It should be noted that a large proportion of the respondents in this survey focus on early-stage investments, when many management teams are still taking shape. Yet, investors' views of management can have a very real impact on a company's financing prospects, with 80% of survey respondents stating that the strength of the management team is a deciding factor in their investment decision.
Do life science management teams themselves view leadership talent as a challenge? Do they struggle to recruit and retain senior management or other key personnel within their companies? If hiring is a problem, what lies behind this? Is it due to a lack of resources to offer a competitive pay and benefits package or are there too few potential recruits with the required skills?
We want to hear from senior executives from biotech, medtech, medical devices, diagnostics, and digital health companies to help the industry better understand the talent challenges and other hurdles facing them. Take part in the LSX C-Suite Challenges in Life Sciences Survey to share your views and benchmark yourself against peers. The survey takes no more than 10 minutes to complete and all those who take part will receive the final report, as well as the opportunity to be entered into a prize draw worth £100. All responses are strictly anonymous.
Editor's note: The results from the LSX C-Suite Challenges in Life Sciences Survey 2018 are now available to download in the resulting report. Download it for free here:
Feature image © JEGAS RA – stock.adobe.com